TY - JOUR
T1 - Corrigendum
T2 - Homeobox regulator Wilms Tumour 1 is displaced by androgen receptor at cis-regulatory elements in the endometrium of PCOS patients
AU - James, David W.
AU - Quintela, Marcos
AU - Lucini, Lisa
AU - Al Kafri, Nour Al Abdullah
AU - Healey, Gareth
AU - Jones, Nicholas
AU - Younas, Kinza
AU - Bunkheila, Adnan
AU - Margarit, Lavinia
AU - Francis, Lewis W.
AU - Gonzalez, Deyarina
AU - Conlan, R. Steven
N1 - Publisher Copyright:
Copyright © 2024 James, Quintela, Lucini, Al Kafri, Healey, Jones, Younas, Bunkheila, Margarit, Francis, Gonzalez and Conlan.
PY - 2024
Y1 - 2024
N2 - In the published article, there was an error in the author list, and author Nicholas Jones was erroneously excluded. Author Nour Al Abdullah Al Kafri was incorrectly listed as Noor K. Alkafri. The corrected author list appears below. “David W. James, Marcos Quintela, Lisa Lucini, Nour Al Abdullah Al Kafri, Gareth D. Healey, Nicholas Jones, Kinza Younas, Adnan Bunkheila, Lavinia Margarit, Lewis W. Francis, Deyarina Gonzalez, R. Steven Conlan” In the published article, there was an error in the legend for Figure 1 as published. The figure legend included the treatment group cAMP+DHT that is not part of this manuscript. Also, the incorrect dataset and number of patient samples was used. The corrected legend appears below. In the published article, there was an error in Figure 1 as published. Wrong dataset and number of patients used. The corrected Figure 1 and its caption “In vitro decidualization” appear below. In vitro decidualization. Endometrial stromal cells were treated with medium or medium containing cAMP (0.5mM) or cAMP (0.5mM) and MPA (1 x 10-6 M) for 48hrs. Cells were lysed in RLT buffer before storage at -80°C and culture supernatant was collected and stored at -20°C. (A) decidual Prolactin levels of supernatant measured by ELISA in PCOS samples (n=10) vs fertile control (n=8). (B) Quantitative PCR for gene expression of WT1 mRNA normalised to GAPDH. Data presented as mean ± SD; for fertiles (n=8) and PCOS (n=7). Data was analysed by two-way ANOVA and Dunnett’s pairwise multiple comparison test, *p ≤ 0.05. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
AB - In the published article, there was an error in the author list, and author Nicholas Jones was erroneously excluded. Author Nour Al Abdullah Al Kafri was incorrectly listed as Noor K. Alkafri. The corrected author list appears below. “David W. James, Marcos Quintela, Lisa Lucini, Nour Al Abdullah Al Kafri, Gareth D. Healey, Nicholas Jones, Kinza Younas, Adnan Bunkheila, Lavinia Margarit, Lewis W. Francis, Deyarina Gonzalez, R. Steven Conlan” In the published article, there was an error in the legend for Figure 1 as published. The figure legend included the treatment group cAMP+DHT that is not part of this manuscript. Also, the incorrect dataset and number of patient samples was used. The corrected legend appears below. In the published article, there was an error in Figure 1 as published. Wrong dataset and number of patients used. The corrected Figure 1 and its caption “In vitro decidualization” appear below. In vitro decidualization. Endometrial stromal cells were treated with medium or medium containing cAMP (0.5mM) or cAMP (0.5mM) and MPA (1 x 10-6 M) for 48hrs. Cells were lysed in RLT buffer before storage at -80°C and culture supernatant was collected and stored at -20°C. (A) decidual Prolactin levels of supernatant measured by ELISA in PCOS samples (n=10) vs fertile control (n=8). (B) Quantitative PCR for gene expression of WT1 mRNA normalised to GAPDH. Data presented as mean ± SD; for fertiles (n=8) and PCOS (n=7). Data was analysed by two-way ANOVA and Dunnett’s pairwise multiple comparison test, *p ≤ 0.05. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
KW - AR
KW - decidualization
KW - endometrium
KW - epigenomics
KW - polycystic ovary syndrome
KW - transcription
KW - WT1
UR - http://www.scopus.com/inward/record.url?scp=85208626749&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85208626749&partnerID=8YFLogxK
U2 - 10.3389/fendo.2024.1450375
DO - 10.3389/fendo.2024.1450375
M3 - Comment/debate
AN - SCOPUS:85208626749
SN - 1664-2392
VL - 15
JO - Frontiers in Endocrinology
JF - Frontiers in Endocrinology
M1 - 1450375
ER -